(Q33159907)

23 July 2017

1 reference

title

HPV infection and cervical disease: a review (English)

1 reference

23 July 2017

Jonathan R Carter

1

1 reference

23 July 2017

Zongqun Ding

series ordinal

2

1 reference

23 July 2017

Barbara R Rose

series ordinal

3

1 reference

23 July 2017

language of work or name

1 reference

28 January 2011

1 reference

Australian and New Zealand Journal of Obstetrics and Gynaecology

23 July 2017

published in

1 reference

23 July 2017

volume

51

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

103-108

1 reference

Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

The health care costs of cervical human papillomavirus--related disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

The epidemiology of genital human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Classification of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Cervical cancer prevention--cervical screening: science in evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Epidemiology of Genital Human Papillomavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Current understanding of the mechanism of HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Prophylactic HPV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

Passive versus active parental permission in school-based survey research: does the type of permission affect prevalence estimates of risk behaviors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1479-828X.2010.01269.X

10.1111/J.1479-828X.2010.01269.X

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference